Promising Drugs Targeting Specific Mechanisms of Deregulation in T Cell Lineage Acute Lymphoblastic Leukemia
Abstract T cell acute lymphoblastic leukemia (T-ALL) is a class of hematological malignancies predominantly affecting children, adolescents, and young adults, marked by aggressive behavior and poor clinical response, especially in relapsing cases. Advances in molecular biology for the last decade ha...
Saved in:
| Main Author: | Xavier Thomas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Oncology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40487-025-00339-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deregulation as an Effort to Improve Public Services in Indonesia
by: Marlan Hutahaean, et al.
Published: (2024-01-01) -
Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
by: Ziyi Hao, et al.
Published: (2024-12-01) -
Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System
by: Minori Tamai, et al.
Published: (2025-03-01) -
THE URGENCY OF DEREGULATION TO MANIFEST A SINGLE NATIONAL EDUCATION SYSTEM AS MANDATED IN CONSTITUTION
by: Pandu Ario Bismo, et al.
Published: (2024-01-01) -
Efficiency of Inotuzumab Ozogamicin in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Relation to CD22 Expression
by: Thulasi Raman Ramalingam, et al.